321550 — TiumBio Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for TiumBio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-12,119	-32,253	-31,402	-19,038	-23,546
Depreciation
Amortisation
Non-Cash Items	213	3,226	12,456	-5,707	4,995
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	1,509	2,281	-538	875	-875
Change in Accounts Receivable
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-9,379	-24,802	-16,013	-20,616	-15,628
Capital Expenditures	-895	-11,889	-11,321	-18,361	-1,045
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	10,467	-12,902	35,713	8,730	25,726
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	9,572	-24,792	24,392	-9,632	24,681
Financing Cash Flow Items	-5.32	3,011	-0.928	-97.3	1,992
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	598	53,020	2,784	22,979	-2,753
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	580	3,417	11,250	-7,621	5,945